SPAK mediates KCC3-enhanced cervical cancer tumorigenesis

FEBS J. 2014 May;281(10):2353-65. doi: 10.1111/febs.12787. Epub 2014 Apr 7.

Abstract

Ste20-related proline/alanine-rich kinase (SPAK) plays a role in regulating many biological activities, and interacts with K-Cl co-transporter 3 (KCC3); however, the importance of SPAK for KCC3 function has not been demonstrated. Here, we investigated the role of SPAK in KCC3-regulated cell invasiveness and tumor formation. We show that induction of KCC3 expression triggers activation of the NF-κB and SPAK signaling cascades, leading to activation of p38 mitogen-activated protein kinase (MAPK) and matrix metalloproteinase-2 (MMP2). A small interference RNA-mediated reduction in SPAK protein levels suppressed the invasive ability and oncogenic potential of cervical cancer cells, and decreased tumor formation in mouse xenografts. A combination of experimental approaches, including RT-PCR and real-time RT-PCR, gelatin zymography, NF-κB luciferase activity and chromatin immunoprecipitation assays, showed that the induction of KCC3 over-expression increased MMP2 expression and augmented binding of NF-κB to its putative SPAK promoter binding site, suggesting that the SPAK/MMP2 axis is up-regulated by NF-κB. Pharmacological inhibition of NF-κB or MMP2 abrogated KCC3-triggered, SPAK-dependent cell invasiveness. Furthermore, p38 MAPK was identified as the upstream regulator of KCC3-dependent MMP2 activation. We conclude that SPAK may promote KCC3-mediated tumor aggressiveness via the NF-κB/p38 MAPK/MMP2 axis.

Keywords: KCC3; NF-κB; Ste20-related proline/alanine-rich kinase; matrix metalloproteinase; tumor aggressiveness.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins / metabolism
  • Animals
  • Cell Line, Tumor
  • Female
  • HEK293 Cells
  • HeLa Cells
  • Heterografts
  • Humans
  • Matrix Metalloproteinase 2 / metabolism
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • NF-kappa B / metabolism
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Promoter Regions, Genetic
  • Protein Binding
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • RNA, Neoplasm / genetics
  • RNA, Neoplasm / metabolism
  • RNA, Small Interfering / genetics
  • Signal Transduction
  • Symporters / genetics
  • Symporters / metabolism*
  • Uterine Cervical Neoplasms / etiology*
  • Uterine Cervical Neoplasms / genetics
  • Uterine Cervical Neoplasms / metabolism*
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Actins
  • NF-kappa B
  • RNA, Messenger
  • RNA, Neoplasm
  • RNA, Small Interfering
  • SLC12A6 protein, human
  • Symporters
  • Protein Serine-Threonine Kinases
  • STK39 protein, human
  • p38 Mitogen-Activated Protein Kinases
  • MMP2 protein, human
  • Matrix Metalloproteinase 2